NASDAQ:PME Archives - Market Exclusive

Home Tags NASDAQ:PME

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - April 18, 2018

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - April 17, 2018

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - January 25, 2018

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - January 12, 2018

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - January 5, 2018

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Submission of Matters...

ME Staff 8-k - December 19, 2017

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - December 12, 2017

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Results of Operations...

ME Staff 8-k - August 10, 2017

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - July 27, 2017

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Results of Operations...

ME Staff 8-k - July 17, 2017

12 3 Page 1 of 3

EDITOR PICKS

Market Exclusive Daily Roundup, What You Need To Know April 18

April 18, 2018

Here’s What Happened Last Week In Biotech

April 17, 2018

ArQule, Inc. Is Moving On ASCO Release, Here’s Why.

April 16, 2018

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NASDAQ:PME

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Submission of Matters...

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Results of Operations...

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Regulation FD Disclosure

PINGTAN MARINE ENTERPRISE LTD. (NASDAQ:PME) Files An 8-K Results of Operations...

EDITOR PICKS

Market Exclusive Daily Roundup, What You Need To Know April 18

Here’s What Happened Last Week In Biotech

ArQule, Inc. Is Moving On ASCO Release, Here’s Why.

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY